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Background: The primary human bone-derived cell culture technique is used as
a model to study human osteogenesis. Compared to cell line cultures, primary
osteoprogenitor and osteoblast cultures provide more complex information about
osteogenesis, bone remodeling and regeneration than cell line cultures.
Methods: In this study, we isolated human bone-derived cells (HBDCs) and
promoted their differentiation into osteoblasts. The following parameters were
evaluated: cell number and viability, total protein expression, alkaline phosphatase
activity, collagenous matrix production and osteogenic genes expression, i.e., gene
coding for type I collagen and alkaline phosphatase.
Results: It was proved the results show that HBDCs intensively proliferate during
the first 7 days of culture followed by differentiation accompanied by an increase
in alkaline phosphatase activity. Moreover, it was observed that during the
differentiation of HBDCs, the expression of integrin β1 increased.
Conclusions: The process was also accompanied by changes in cell shape and
rearrangement of the actin cytoskeleton and focal contacts containing FAK and the
integrin β1 subunit. We suggest that the β1 integrin subunit may be a suitable new
target in studies of the differentiation of primary human osteoblasts in culture.
Keywords: Human bone-derived cells, Integrins, Osteoblast differentiation,
Osteogenesis in vitro, Osteogenic markers, Primary osteoblastsBackground
Bone is a highly organized structure of calcified connective tissue formed during osteo-
progenitor proliferation and differentiation into mature osteoblasts. Osteoblasts (bone-
forming cells) are identified on the basis of morphology – their cuboidal appearance – and
their association with bone matrix.
Osteoblast maturation consists of three main phases: proliferation, extracellular matrix
(ECM) synthesis, and mineralization [1]. Osteoblast differentiation from their undifferen-
tiated to functional state is accompanied by changes in cell morphology and in the
expression of adhesion molecules, ECM proteins (collagen type I; COLI) and specific
osteogenic markers, i.e., alkaline phosphatase (ALP), osteocalcin (OC), osteopontin (OP),
osteonectin (ON) and bone sialoprotein (BSP). ALP is considered a relative early marker
of osteoblast differentiation [2]. The subsequent reconstruction of a collagenous matrix
occurs in the course of procollagen I mRNA decrease [3] and OC expression increase, a
late marker of differentiated osteoblasts [1].© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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cell lines (e.g., MG-63 or SaOS-2), induced osteoblasts from pluripotent stem cells, and
harvested primary osteoblasts [4, 5]. The potential of in vitro cultured osteoblasts to
maintain their phenotype and activity depends on the cell type used. In the case of pri-
mary osteoblasts, cell phenotype and potential depends on the age, site of isolation,
donor gender and method of cell isolation and culture [5, 6]. The primary osteoblast
culture could be obtained in the process of progressive enzymatic digestion of bone
tissue [7] or cell migration from the bone explants [6]. Generally, using such a factor as
ascorbic acid, 1α,25-dihydroxyvitamin D3 and dexamethasone, it is possible to induce
osteogenesis of stem or progenitor cells, such as mesenchymal stem cells or induced
pluripotent stem cells, or of osteoprogenitors and osteoblasts [5, 8–11]. In this study,
we concentrated on the osteogenic potential of human bone-derived cells (HBDCs)
obtained from bone explant enzymatic digestion and cultured in vitro.
Human osteogenic cells derived from various bone compartments are routinely estab-
lished in short-term cultures. These cultures are heterogeneous and consist of different
bone cell subpopulations. The subpopulations seem to be primary osteoprogenitor, pre-
mature and mature osteoblasts at various stages of differentiation [12]. Moreover, it was
also described that in vitro HBDCs were able to differentiate into multiple mesenchymal
lineages, suggesting their multipotent character [13, 14]. Importantly, the primary osteo-
blast cultures provide more complex information about osteogensis, bone remodeling and
regeneration than cell line cultures. The differences between primary osteoblasts and cell
line cultures should be taken into account when studying processes of osteoblast differen-
tiation in vitro. The growth and differentiation of HBDCs is regulated by growth factors,
cytokines and hormones, and also depends on the cell density in culture [5]. In this study,
we focused on the role of cell adhesion in HBDC differentiation.
Cell adhesion supports tissue morphogenesis integrity as well as tissue repair. Bone
cell adhesion to the extracellular matrix directly regulates cell growth, the expression of
the osteoblast phenotype and the process of bone tissue formation [15].
Integrins are the adhesion molecules involved in the process of cell adhesion.
Integrin-mediated adhesion is a highly regulated process involving receptor–ligand in-
teractions and cell spreading. Upon ligand binding, integrins rapidly associate with the
actin cytoskeleton and cluster together to form focal contacts, which are complexes
composed of structural and signaling molecules such as focal adhesion kinase (FAK).
Focal adhesions act as structural links between the cytoskeleton and extracellular
matrix and mediate stable cell adhesion and migration [16]. The binding of transmem-
brane integrin adhesion receptors to ECM components, such as fibronectin and COLI,
activates signaling pathways engaged in cell-cycle progression, gene expression, matrix
mineralization and survival of primary osteoblasts [17]. Osteoprogenitor cells and osteo-
blasts express multiple integrins, including α1β1, α2β1, α3β1, α4β1, α5β1, α8β1 and αvβ3,
which bind to numerous ECM proteins [18]. Blocking adhesion with COLI-specific
peptides or antibodies directed against the collagen-binding integrin α2β1 affects with
the activity of Runx/Cbfa1 transcription factors, expression of osteoblast-specific genes,
and matrix mineralization [19].
The purpose of this study was to characterize HBDC phenotypes by defining cell
morphology changes and the proliferation and differentiation rate. We also analyzed
actin cytoskeleton organization and adhesive protein expression. The phonotype of
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ture conditions, including medium, time and the presence of compounds that influence
cell proliferation and differentiation [20]. The primary focus of this study was HBDC
biology in vitro as part of an evaluation of their tissue engineering potential.
Methods
The Local Ethics Committee of the Warsaw Medical University approved all procedures
(Decision No. KB/74/2005). All of the donors provided informed consent.
Primary culture of HBDCs
Human bone-derived cells (HBDCs) were isolated from trabecular bone tissue chips
harvested from the bottom distal part of the long tight bone during standard procedure
knee joint alloplasty. Material from seven female patients ranging in age from 59 to 63
was used. Cells harvested from different donors were cultured separately. The procedure
of HBDC isolation was based on the protocols described by Gallagher et al. [21] with
modifications [22].
Briefly, the extracted bone pieces were purified from other tissues by scraping, and
the bone was cut into 1-mm pieces and washed with phosphate-buffered saline (PBS)
containing Ca2+ and Mg2+ ions (Gibco BRL, Life Technologies B.V. Breda, The
Netherlands),.), and subsequently digested overnight using a collagenase XI S (200 U
ml−1; Sigma-Aldrich, St. Louis, USA).).
Next, samples were washed with PBS and placed in a 75-cm3 cell culture flasks (Costar-
Nunc), containing the standard culture medium: Dulbecco’s modified Eagle’s medium
(DMEM; Gibco) supplemented with a 10% final concentration of heat-inactivated fetal
bovine serum (FBS; Gibco), L-glutamine (Gibco), a 1% antibiotic–antimycotic mixture
consisting of 10,000 U of penicillin (base), 10 mg of streptomycin (base) and 25 μg of
amphotericin B ml−1 (Gibco), and 100 mM L-ascorbic acid 2-phosphate hydrate sesqui-
magnesium salt (Sigma-Aldrich).
The explants were cultured in a CO2 incubator at 37 °C in 5% CO2 and humidified
atmosphere. The medium was changed every 7 days. Within 2–4 weeks, osteoblast
migration from the bone explants was observed. Then the explants were placed in two
or three different flasks to obtain two populations of cells originating from the same
donor. After confluence, HBDCs were detached using collagenase and trypsin/EGTA
(Gibco) treatment.
The cells from the first passage were used in all of the experiments. Cells were seeded
in 24-well dishes at a density of 4 × 104 cells per well (1.9 cm2) in a differentiating
medium containing 10 nM dexametasone (Sigma-Aldrich) and 100 nM 1α,25-dihydrix-
ycholecalciferol (Sigma-Aldrich) to induce osteogenesis. The morphology of the cells
was analyzed using an inverted, phase-contrast microscope (Nikon Eclipse TE2000-u).
Evaluation of cell proliferation and viability
To evaluate cell proliferation, HBDCs were plated at a density of 4 × 104 cells per well
in differentiating medium. The cell growth curve was assessed on the basis of cells
number counted using a Burker’s camera. Subsequently, the adherent cells were enzy-
matically detached from the surface of wells using 1 mM EDTA and 0.25% trypsin and
the cell number was determined in a counting chamber.
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the manufacturer’s protocol. Cell cultures were washed three times with PBS, and then
XTT working solution was added and left for 4 h at 37 °C. The final product of the re-
action was measured using a FLUOstar OPTIMA ELISA plate reader (BMG LABTECH
GmbH) at 450 nm. The cell number and viability on days 1, 7, 14 and 21 of culture
was determined. Seven independent experiments were performed. The data are presented
as means ± standard deviation. Student’s t-test was used for statistical analysis to compare
the results. p < 0.05 was considered significant.Determination of alkaline phosphatase (ALP) activity
The culture medium was removed and the wells were washed three times with PBS,
and then lysed for 1 h at 4 °C with cell lysis buffer consisting of 10 mM Tris-HCl
(pH 7.5) and 0.1% Triton X-100 (Sigma). Then, 50 μl of the lysates were assayed using
p-nitrophenyl phosphate substrate (Sigma) according to the manufacturer’s instruc-
tions. The colorimetric reaction was carried out at 37 °C for 30 min, then stopped using
3 M NaOH and EDTA solution. The absorbance of the reaction product was deter-
mined at 405 nm using the FLUOstar OPTIMA ELISA reader. The ALP activity (U/cell
number) was measured on days 7, 14 and 21. Seven independent experiments were per-
formed. The data are presented as means ± standard deviation. Student’s t-test was used
for statistical analysis to compare the results. p < 0.05 was considered significant.Total protein content assay
On days 7, 14 and 21 of culture, the total protein content was determined in the cell ly-
sates using a Protein Assay BCA kit (Pierce Biotechnology, Inc., Rockford, USA). Test.).
The test was done according to the manufacturer’s protocol. Absorbance was measured
at 562 nm and the total protein content was calculated. Seven independent experiments
were performed. The data are presented as means ± standard deviation. Student’s t-test
was used for statistical analysis to compare the results. p < 0.05 was considered significant.Determination of collagen production
The collagen assay is based on binding of Sirius red dye to the triple helical collagen
fibril. On days 7, 14 and 21 of culture, the cells were washed three times with PBS, and
then 0.1% Sirius red in saturated picric acid was added (Sigma-Aldrich), and incubated
for 60 min at room temperature. Then the plates were rinsed three times with 10 mM
HCl. The presence of collagen was observed under an inverted microscope (Nikon
Eclipse TE2000-u). The collagen-binding stain was finally eluted with 0.1 M NaOH and
absorbance was read at 540 nm using the FLUOstar OPTIMA ELISA reader. Seven
independent experiments were performed. The data are presented as means ± standard
deviation. Student’s t-test was used for statistical analysis to compare the results. p < 0.05
was considered significant.Actin microfilaments staining
HBDCs were plated at a density of 2 × 104 cells on a cover slide (1.9 cm2) in standard
medium. The next day, the cells were treated with differentiating medium. On days 7,
14 and 21 of culture, the attached cells were washed three times with PBS (Gibco),
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PBS (Sigma) for 1 min at room temperature. The washing step was followed by incubation
with TRITC-conjugated phalloidin (Sigma-Aldrich) diluted in PBS (1:200) for 40 min, at
room temperature. After a final wash in PBS, specimens were mounted in Ultra Cruz
Mounting Medium containing DAPI (Santa Cruz Biotechnology, Santa Cruz, CA) and
observed using a fluorescent microscope (Nikon Eclipse TE2000-u) connected to Nikon
Digital Sight DS-U1 camera. Three independent experiments were performed and
representative images are shown.Immunofluorescence localization of β1 integrin subunit and FAK
HBCS were seeded at a density of 2 × 104 cells on a cover slide in standard medium.
The next day, they were treated with differentiating medium. On days 7, 14 and 21 of
culture, the cells were washed in PBS and fixed with 3% formaldehyde in PBS (Gibco).
Then, the cells were permeabilized in 0.1% Triton X-100 in PBS, washed three times
in PBS and incubated in 0.25% glycine in PBS for 30 min at room temperature. Non-
specific binding was blocked with 3% bovine serum albumin (BSA, Sigma) diluted in
PBS for 30 min. Cells were incubated with primary antibody overnight at 4 °C. Primary
antibodies were mouse monoclonal anti-β1 integrin (Santa Cruz Biotechnology) and
mouse monoclonal anti-FAK (Santa Cruz Biotechnology). They were diluted 1:100 in
3% BSA/PBS. Then, the cells were washed in PBS and incubated with secondary
biotin-conjugated antibodies (1:100 in 3% BSA/PBS; Santa Cruz Biotechnology),
followed by incubation with Extravidin-TRITC (1:100 in 3% BSA/PBS; Sigma-Aldrich).
Unlabeled cells and cells labeled with a secondary biotin-conjugated antibody and with
extravidin–TRITC were used as a control.
After a final wash in PBS, specimens were mounted in Ultra Cruz Mounting Medium
containing DAPI (Santa Cruz Biotechnology). Images of stained cells were captured
using a fluorescent microscope (Nikon Eclipse TE2000-u) connected to Nicon Digital
Sight DS-U1 camera. Three independent experiments were performed and representative
images are shown.Semi-quantitative RT-PCR assay
Total RNA was isolated from cells harvested on day 0, with the cells under non-
differentiating conditions in the standard medium, and on days 7, 14 and 21, with the
cells cultured with differentiating medium, using a High Pure Isolation Kit (Roche
Diagnostics U.S. Heagquarters, Indianapolis, USA).). Specific transcripts were amplified
using semi-quantitative RT-PCR with 1 μg of total RNA as a template and specific
oligonucleotide primers, using a Titan One-Tube RT-PCR Kit (Roche Diagnostics),
according to the manufacturer’s instructions. The sequence of the oligonucleotides
used in the RT-PCR was determined based on the literature review (Table 1). The
oligonucleotides were synthesized by Singen Biotech Sp. z o.o, Wrocław, Poland.
The obtained cDNA fragments were separated on 2% agarose LE gels (Roche Diag-
nostic). The gels were stained with ethidium bromide and the optical density (Odu) of
bands was analyzed with Gel Doc 2000 software (Bio-Rad, Hercules, CA, USA). To
evaluate the expression levels of transcripts in a semi-quantitative manner, the optical
densities of the amplified cDNA fragments were compared with the average density
Table 1 List of primers used in the RT-PCR analysis










β1 integrin subunit F 5-’AAGGGCGTGTTGGTAGACATT-3’
R 5’-TGACACATCTCACACGTTTGC-3’
424
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pendent experiments is presented.Results
The primary HBDC culture serves as a suitable model to study osteogenesis. For a
comprehensive examination of HBDCs in vitro, the cells were cultured under condi-
tions that allow osteoblast differentiation. The following parameters were evaluated: cell
number and viability, total protein content, alkaline phosphatase activity, collagenous
matrix production, expression of the osteogenic genes ALP and COLI, localization, and
expression of the actin cytoskeleton and two proteins engaged in cell adhesion: β1 integrin
subunits and FAK.
The cultures obtained from bone explants of seven different patients were evaluated.
The HBDCs were analyzed 24 h after cell seeding, i.e., during the adhesion phase, on
day 7 of culture, i.e., during the proliferation stage, and on days 14 and 21 of culture,
i.e., during the early and late maturation stages.Culture of HBDCs
Morphological changes were observed to accurately characterize the primary human
osteoblast culture (Fig. 1). Long and narrow fibroblast-like cells were observed during
the adhesion (Fig. 1a) and proliferation stages (days 7 and 9, Fig. 1b, c). On days 14 and
17 of culture (Fig. 1d, e), the cell morphology had changed to a cuboidal shape. Finally,
on day 21 of culture (Fig. 1f ), the cells became elongated. Analysis of the proliferation
curve and cell viability showed that HBDCs intensively proliferate during the first 7 days
of culture (Fig. 2). Thereafter, as measured on days 14 and 21, the proliferation and cell
viability increased at a lower rate (Fig. 2).Phenotypic characteristics of HBDCs
To evaluate the osteoblast phenotype, we used semi-quantitative RT-PCR to investi-
gate the gene expression of the osteoblast markers type I collagen (COLI) and alka-
line phosphatase (ALP). Samples were obtained from primary human osteoblasts
cultured in undifferentiating conditions (standard medium, point 0) and on days 7,
14 and 21 of culture in differentiating medium. We compared the average density of
the GAPDH mRNA band (set to 100%) with the bands corresponding to COLI and
ALP mRNAs (Fig. 3) and found that the highest level of mRNA encoding COLI was
observed at point 0, when HBDCs were growing in standard medium. On day 7, it
Fig. 2 The cell number and viability (XTT assay) 24 h after cell seeding, and on days 7, 14 and 21 of culture.
The results of the XTT assay are presented as the absorbance level. It was determined as a linear relationship
between cell number and viability. Seven independent experiments were performed. The data are presented
as means ± standard deviation. Cell number is in black; cell viability is in grey. Student’s t-test was used for
statistical analyses. *p < 0.05 (considered significant)
Fig. 1 Morphological changes of HBDCs during their in vitro differentiation. The cells were cultured in
differentiating medium. Phase contrast images were taken 24 h after cell seeding (a), and on day 7 (b), 9
(c), 14 (d), 17 (e) and 21 (f) of culture. The morphology of HBDCs changed from a fibroblastic-like to a
cuboidal shape. Seven independent experiments were performed and representative images are shown.
Scale bar: 100 μm
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Fig. 3 Expression of osteoblast markers, i.e., type I collagen (COLI), alkaline phosphatase (ALP), osteocalcin
(OC) determined using semi-quantitative RT-PCR. Analysis of the representative gels and the level of GAPDH,
COLI, ALP and OC mRNA (the average optical density of bands; Odu) is presented in the charts (n = 3). Results
are normalized to the housekeeping gene level (GAPDH). 0 – cell cultured under undifferentiating conditions
in standard medium; 7, 14, 21 – cells cultured under osteogenic conditions in differentiating medium
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creased again, and reached the same level as observed at point 0 on day 14, main-
taining this level through day 21. During the differentiation of HBDCs the level of
ALP mRNA was the highest on day 7, then decreased 1.6-fold and 1.5-fold by days
14 and 21 respectively. There was no difference in the ALP expression level between
days 14 and 21.
The differentiation of human osteoblasts is associated with an increase in total
protein synthesis (Fig. 4a), constant production of collagen (Fig. 4b) and an increase
in ALP activity (Fig. 4c). At all stages of HBDC differentiation, there was no major
difference in collagen production by the cells (Fig. 4b). The results of these analyses
precisely reflect those obtained via collagen staining, where all HBDCs in culture
showed the presence of collagen (Fig. 5). By contrast, the ALP enzymatic activity
increased significantly from day 14 until 21 (maturation stage; Fig. 4c).
Changes in actin organization and adhesive proteins expression during HBDCs
differentiation
To answer the question of how cytoskeleton organization and adhesion proteins ex-
pression changed during HBDC differentiation, we analyzed FAK, β1 integrin and
actin localization in vitro. At first, we analyzed the expression of mRNA encoding β1
integrin subunits (Fig. 6a). The level of the integrin β1 subunit increased during cell
differentiation, and its mRNA was the highest on day 14 of culture. The β1 integrin
subunit visualized with immunocytochemistry was expressed in undifferentiated ad-
herent cells (Fig. 6b) and in differentiating HBDCs (Fig. 6c, d). The β1 integrin sub-
unit was distributed in the membrane and focal contacts (Fig. 6b–d). Moreover,
differentiating HBDCs (day 21) formed numerous focal adhesion contacts, as shown
via immunolocalization of FAK, i.e., kinase was engaged in their formation (Fig. 6e).
Actin filaments were stained with phalloidin–TRITC (Fig. 6f–h), and many stress
fibers were clearly visible in the cells during proliferation (Fig. 6f, g). The actin fila-
ments were also detected at maturation stage (Fig. 6h). By day 7 of culture, HBDCs
had spread to form numerous actin stress fibers, observed as long, linear, well-
defined filaments arranged in large bundles tending to run parallel to each other
Fig. 4 The total protein content (a), collagen assay (b) and alkaline phosphatase (ALP) activity (c). The
results of the collagen assay are presented as the absorbance level. The results from seven separate
experiments are shown. The data are presented as means ± standard deviation. Student’s t-test was used
for statistical analyses. *p < 0.05 (considered significant)
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cells having cuboidal shape and being substantially less spread. Actin cytoskeleton
distribution had also started to change (Fig. 6g). In the last phase of osteoblast differ-
entiation, the concentration of actin was the highest and a complex network of actin
filaments was detected (Fig. 6h). Thus, differentiation of HBDCs accompanies
reorganization of the actin cytoskeleton.
Fig. 5 Localization of collagen during differentiation of HBDCs on days 1 (a), 7 (b), 14 (c) and 21 (d). Three
independent experiments were performed and representative images are shown. Scale bar: 100 μm
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Human osteogenic cells can be isolated from human bone and are able to differentiate
and produce ECM proteins, which are the substrate for mineralization during bone
formation. The aim of this study was to characterize the HBDC phenotype and inves-
tigate the osteoblast potential of these cells in vitro. Differentiation of HBDCs has
been described as a three-step process consisting of the adhesion phase, proliferation
phase and osteoblast maturation.
HBDCs are considered a source of cells for a therapy. The characteristics of these
phases at molecular level are very important when considering using autologous bone
transplants for human bone reconstruction. Isolated osteoblast cells prepared for implant-
ation could be differentiated in vitro [23]. To induce differentiation of isolated HBDCs, a
differentiating medium containing vitamin C, vitamin D3 and dexamethasone was used.
The role of vitamin C is to stimulate the synthesis of COLI [24]. Dexamethasone is a
synthetic glucocorticosteroid that inhibits proliferation and induces differentiation of
progenitor cells to osteoblast phenotype [25]. Vitamin D3 and dexamethasone regulate
the differentiation of osteoblasts affecting the level of ALP expression and activity [26].
In this study, we used HBDCs from the first passage. As shown by Coelho et al., serial
cell passages affect the number of cells and lead to a loss of the osteoblast phenotype [27].
It was noticed that the proliferation and viability of HBDCs first increased and then grad-
ually stopped, starting from day 14 of culture, i.e., when the cells began to differentiate.
Markers such as ALP and COLI were monitored to assess the osteoblast potential of
isolated HBDCs. The level of ALP mRNAs is one of the crucial factors to determine
osteoblast differentiation. It is known that the expression of ALP mRNA is present in
the early stages of osteoblast differentiation, increasing in mature osteoblasts and de-
creasing when osteoblasts differentiate to osteocytes [28]. Our results showed that ALP
mRNA was detected in undifferentiated HBDCs, increased at the proliferation stage
and slightly decreased during cell maturation. The time course of ALP gene expression
Fig. 6 (See legend on next page.)
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Fig. 6 Changes in the expression levels and localization of the β1 integrin subunit during differentiation of
HBDCs. a Analysis of representative gels. The levels of GAPDH and β1 integrin subunit mRNA are shown in
the charts. Results are normalized to the level of the housekeeping gene (GAPDH). 0 – cell cultured under
undifferentiating conditions in standard medium; 7, 14, 21 – cells cultured under osteogenic conditions in
differentiating medium. b, c, d Immunolocalization of the β1 integrin subunit on days 7 (b), 14 (c) and 21
(d) of HBDC differentiation. Three independent experiments were performed and representative images are
shown. Scale bar: 100 μm. e Immunofluorescence staining for osteoblasts terminating in focal adhesion
contacts as shown by FAK localization (on day 21 of HBDC culture). Focal adhesion plaques indicated
by a white arrowhead. Three independent experiments were performed and representative images are
shown. Scale bar: 100 μm. f–h Localization of actin in differentiating HBDCs on days 7 (f), 14 (g) and 21
(h) of culture. Three independent experiments were performed and representative images are shown.
Scale bar: 100 μm. i Cell adhesion to ECM proteins is mediated through integrin receptors, which are
clustered within adhesive cellular structures known as focal adhesion or focal contact plaques. Focal
adhesion plaques are supramolecular assemblies containing structural (talin, vinculin, tensin, actin
filaments) and signaling components (FAK, Src, paxilin) regulating cell functions via integrins
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[29]. The increase in ALP activity correlates with the formation of bone-like structures
in vitro [30]. Our study showed that ALP activity was detectable 24 h after cell seeding
and increased during human osteoblast maturation.
The expression level of osteogenic markers varied depending on the donors, but the
trends were the same. The extracellular matrix of the bone is composed of 90% col-
lagenic proteins (type I collagen 97%, type V collagen 3%) and 10% non-collagenic
proteins (osteocalcin 20%, osteonectin 20%, bone sialoproteins 12%, proteoglycans
10%, osteopontin, fibronectin, bone morphogenic proteins, etc.). All these proteins are
synthesized by osteoblasts and most are involved in cell adhesion. Fibrillar COLI, the
predominant organic matrix composite in bone, functions as a three-dimensional
template to control the spatial aspect of mineralization. The covalent intermolecular
cross-links are the final collagen post-translation modification crucial for the stability
of the fibrils. 1,25(OH)2D3 regulates collagen post-translational modifications and
maturation in osteoblast cell culture [31].
We demonstrated that isolated and cultured HBDCs changed their morphology and
that the expression and activity of ALP increased. Thus, the cells were able to differ-
entiate in vitro into osteoblasts. However, the level of COLI mRNA and protein, the
major component of ECM in bone tissue, did not differ significantly during HBDC
differentiation. Nevertheless, as shown previously, the expression of osteocalcin also
increased during differentiation of HBDCs cultured under the same conditions [28].
Bone cell differentiation from the undifferentiated state into functional active osteo-
blasts is a series of steps involving numerous proteins expressed at each stage [32, 33].
Cell adhesion to the substrate is the first phase of the reaction between cells and the
extracellular substrate determining the morphology, proliferation and differentiation
ability of cells. The oval HBDCs adhere to the surface of a culture dish and change into
an elongated shape. This process was connected with reorganization of actin filaments
and the formation of focal contacts. The architecture of the actin cytoskeleton is essen-
tial to maintain cell shape and signaling leading to proliferation or differentiation
in vitro [34]. Also, inhibition of cell proliferation and induction (initiation) of cell differ-
entiation was observed. During this process, HBDCs change shape, actin cytoskeleton
reorganization is noticeable and there are an increased number of focal contacts
containing FAK and the integrin β1 subunit.
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the differentiation of human osteogenic cells [35]. In this study, we focused on other
proteins engaged in the formation of focal contacts, i.e., β1 integrin subunits and
FAK. Focal contacts are the sites of adhesion between cultured cells and extracellular
proteins. Membrane receptors such as integrins play a key role in the formation of
focal contacts and link extracellular proteins with the actin cytoskeleton. Numerous
proteins like talin, paxillin and vinculin are known to mediate interactions between
actin filaments and integrins [36]. Via numerous signaling molecules, integrins con-
nect to the actin cytoskeleton and mediate transduction of signals from the extracel-
lular matrix to the cell nucleus [37]. All bone cell types expressed α1 and α5 subunits,
whereas a subpopulation of osteoblast cells expressed α2, αv and β1 integrin subunits
[38]. Human osteoblasts cultured in vitro expressed a high level of α1β1, α3β1, α5β1
and αvβ5 and much lower levels of α2β1, α4β1, αvβ1 and αvβ3 integrins.
The main receptor mediating adhesion between osteoblasts and extracellular matrix
proteins is the β1 integrin subunit [39]. β1 integrin directly binds a number of struc-
tural and regulatory proteins of focal contacts, such as talin [40] and FAK [41]. It was
shown that human osteoblasts cultured on substrates containing tripeptide RGD
(Arg-Gly-Asp) express the αv and β1 integrin subunits [42]. The RGD motif that is
present in several bone matrix proteins is a ligand for integrins and stimulates osteo-
blast adhesion to the substrate [43]. We previously showed that αv integrin subunit
expression significantly increases during HBDC differentiation into osteoblasts [35].
In this study, we demonstrated that expression of the β1 integrin subunit increases
during HBDC differentiation. Moreover, both proteins, i.e., the αv [35] and β1 integ-
rin subunits, were localized in numerous focal contacts formed during HBDC
differentiation.Conclusions
HBDC differentiation is associated with changes in cell shape, the production of collagen
and an increase in ALP activity, as well as with the reorganization of actin cytoskeleton
and an increased number of focal contacts containing FAK and the integrin β1 subunit.
An increase in integrin β1 subunit mRNA expression was also recorded. Thus, we suggest
that integrin αv [35] and β1 can be considered as markers of osteogenic differentiation.
Moreover, the αv and β1 integrin subunits may be suitable new candidates to evaluate the
differentiation of primary human osteoblasts in culture.
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